Physician profile
Robert M Coben
NPI 1891754891
$3,249.62
in general payments reported to CMS, 2019-2025
16 companies · $62.42 in 2025
The $62.42 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2021: $105 · 2022: $540 · 2023: $1,317 · 2024: $54.90 · 2025: $62.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,166 · Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,166.00 |
| Food and Beverage | $268.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,236.17 | 2019-2024 | Xifaxan, Plenvu |
| Fujifilm Healthcare Americas Corporation | $182.22 | 2022-2024 | Fujifilm |
| Boston Scientific Corporation | $175.34 | 2022-2023 | Acquire |
| Medtronic, INC. | $140.07 | 2022 | |
| Covidien LP | $132.39 | 2019 | |
| Abbvie INC. | $67.06 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $64.54 | 2023 | |
| Ferring Pharmaceuticals INC. | $55.13 | 2022-2023 | Cimzia |
| Celgene Corporation | $45.79 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $32.53 | 2025 | Eohilia |
| Phathom Pharmaceuticals, INC. | $29.89 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $26.32 | 2022 | |
| Qol Medical, LLC | $18.74 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.87 | 2021 | |
| Pfizer INC. | $14.55 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.